1970
DOI: 10.1271/bbb1961.34.966
|View full text |Cite
|
Sign up to set email alerts
|

“Nojirimycin” as a Potent Inhibitor of Glucosidase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
33
0

Year Published

1981
1981
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(34 citation statements)
references
References 0 publications
1
33
0
Order By: Relevance
“…The induction medium in 50 mM potassium phosphate buffer (pH 6.0) contained the following (in grams per liter): (NH4)2SO4, 1.4; MgSO4. 7H20, 0.3; Tween 80, 2.0; and sugar to be tested, (20), was added to retard degradation of the inducer. Unless otherwise stated, the concentration of nojirimycin was 10 ,ug/ml.…”
Section: Methodsmentioning
confidence: 99%
“…The induction medium in 50 mM potassium phosphate buffer (pH 6.0) contained the following (in grams per liter): (NH4)2SO4, 1.4; MgSO4. 7H20, 0.3; Tween 80, 2.0; and sugar to be tested, (20), was added to retard degradation of the inducer. Unless otherwise stated, the concentration of nojirimycin was 10 ,ug/ml.…”
Section: Methodsmentioning
confidence: 99%
“…It was the first 5-aminosugar found in nature (Inouye et al, 1968), and is a glucose-analog that has a nitrogen atom instead of oxygen in the pyranose ring. Nojirimycin inhibits both and ~ glucosidases of non-mammalian origin but is a more potent inhibitor of the latter (Niwa et al, 1970;Reese et al, 1971). The amino sugar is a competitive inhibitor of the…”
Section: Nojirimycin (5-amino-5-deoxy-d-glucopyranose)mentioning
confidence: 99%
“…Like the parent compound, 1-deoxynojirimycin is a potent inhibitor of several intestinal ~-glucosidases: sucrase, maltase, isomaltase, glucoamylase (Schmidt et al, 1979). But, contrary to nojirimycin, it is only a weak inhibitor of fl-glucosidases of non-mammalian origin (Niwa et al, 1970;Legler and Jfilich, 1984). Both nojirimycin and l-deoxynojirimycin are fully competitive inhibitors of small intestinal sucrase.…”
Section: -Deoxynojirimycinmentioning
confidence: 99%
“…However, we predicted the presence of some intermediates from DNJ biosynthetic pathway, such as nojirimycin (NJ) and 2-amino-2-deoxy-d-mannitol (ADM) (49). NJ has been identified as iminosugar and is capable in exhibiting an a-glucosidase inhibitory activity (50). Putting these factors into consideration, it is also necessary to investigate the contribution of the non-DNJ components in CBP towards the physiological changes that occur in the present study.…”
Section: Resultsmentioning
confidence: 94%